Immuno-Oncology 2.0, Philadelphia Pharmaceutical Symposium 2018

December 8th, 2018

Crowne Plaza, King of Prussia, PA

Register Now

December 8th, 2018

Crowne Plaza, 260 Mall Blvd Vichit, King of Prussia.

 

Continuing last year's theme, the 2018 Philadelphia Pharmaceutical Symposium is titled "Immuno-Oncology 2.0" and will focus on breakthrough in Immuno-Oncology therapy and emerging new platforms.

Join the vibrant Immuno-Oncology R&D community and exchange ideas with experts from academia and industry. Register Now! Early-Bird Registration will end on Nov 9th.

 

Featured Speakers:

  • Carl June, MD. Perelman School of Medicine, University of Pennsylvania
  • Katrin Rupalla, PhD, MBA. Head of Oncology Development Global Regulatory Science, BMS
  • Scot Ebbinghaus, MD. Vice President and Therapeutic Area Head, Oncology Clinical Research, Merck & Co.
  • Michael Kalos, PhD. Vice President of Immuno-Oncology, Janssen R&D
  • Jean-Pierre Issa, MD. Lewis Katz School of Medicine, Temple University
  • Liang Deng, MD, PhD. Physician Scientist, Associate Member Memorial Sloan Kettering Cancer Canter

Agenda

Morning Theme

Breakthrough Immuno-Oncology Therapies

Afternoon Theme

Emerging New Immuno-Oncology Platforms

 

Register Now

 

2018-11-04T10:42:04+00:00